{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T04:13:48Z","timestamp":1777436028456,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000},"content-version":"am","delay-in-days":325,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21am0101091"],"award-info":[{"award-number":["JP21am0101091"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["2542"],"award-info":[{"award-number":["2542"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.bbrc.2022.01.066","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T02:08:56Z","timestamp":1642644536000},"page":"22-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Compound screening identified gossypetin and isoquercitrin as novel inhibitors for amyloid fibril formations of V\u03bb6 proteins associated with AL amyloidosis"],"prefix":"10.1016","volume":"596","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6169-2061","authenticated-orcid":false,"given":"Daisuke","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0596-1671","authenticated-orcid":false,"given":"Tomohiro","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose M.M.","family":"Caaveiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshito","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4555-2445","authenticated-orcid":false,"given":"Tadashi","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2022.01.066_bib1","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","article-title":"Systemic amyloidosis","volume":"387","author":"Wechalekar","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2022.01.066_bib2","doi-asserted-by":"crossref","first-page":"10664","DOI":"10.1039\/C8CC04396E","article-title":"Immunoglobulin light chain amyloid aggregation","volume":"54","author":"Blancas-Mejia","year":"2018","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bbrc.2022.01.066_bib3","doi-asserted-by":"crossref","first-page":"100636","DOI":"10.1016\/j.blre.2019.100636","article-title":"New developments in diagnosis, risk assessment and management in systemic amyloidosis","volume":"40","author":"Vaxman","year":"2020","journal-title":"Blood Rev."},{"key":"10.1016\/j.bbrc.2022.01.066_bib4","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/ajh.25819","article-title":"Immunoglobulin light chain amyloidosis: 2020 update on diagnosis, prognosis, and treatment","volume":"95","author":"Gertz","year":"2020","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bbrc.2022.01.066_bib5","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3390\/cells10030545","article-title":"Daratumumab in the treatment of light-chain (AL) amyloidosis","volume":"10","author":"Palladini","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2022.01.066_bib6","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1182\/blood-2017-03-771220","article-title":"A\u00a0phase 1\/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis","volume":"130","author":"Sanchorawala","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2022.01.066_bib7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bcp.2017.04.004","article-title":"Natural product-based amyloid inhibitors","volume":"139","author":"Velander","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2022.01.066_bib8","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.3390\/ijms22052341","article-title":"Natural products targeting amyloid beta in Alzheimer's disease","volume":"22","author":"Lee","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2022.01.066_bib9","doi-asserted-by":"crossref","first-page":"112197","DOI":"10.1016\/j.ejmech.2020.112197","article-title":"Non-polyphenolic natural inhibitors of amyloid aggregation","volume":"192","author":"Ma","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbrc.2022.01.066_bib10","doi-asserted-by":"crossref","first-page":"14101","DOI":"10.1021\/bi991131j","article-title":"Thermodynamic instability of human \u03bb6 light chains: correlation with fibrillogenicity","volume":"38","author":"Wall","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2022.01.066_bib11","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jmb.2009.07.078","article-title":"Residual structures in the acid-unfolded states of V\u03bb6 proteins affect amyloid fibrillation","volume":"392","author":"Mishima","year":"2009","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.bbrc.2022.01.066_bib12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/pro.2228","article-title":"Mechanism for retardation of amyloid fibril formation by sugars in V\u03bb6 protein: retardation of Amyloid by Sugar","volume":"22","author":"Abe","year":"2013","journal-title":"Protein Sci."},{"key":"10.1016\/j.bbrc.2022.01.066_bib13","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1016\/j.bbagen.2018.08.006","article-title":"Inhibition of amyloid fibril formation in the variable domain of \u03bb6 light chain mutant Wil caused by the interaction between its unfolded state and epigallocatechin-3-O-gallate","volume":"1862","author":"Abe","year":"2018","journal-title":"Biochim. Biophys. Acta BBA - Gen. Subj."},{"key":"10.1016\/j.bbrc.2022.01.066_bib14","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1074\/jbc.M116.750323","article-title":"Aggregation of full-length immunoglobulin light chains from systemic light chain amyloidosis (AL) patients is remodeled by epigallocatechin-3-gallate","volume":"292","author":"Andrich","year":"2017","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2022.01.066_bib15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF00197809","article-title":"NMRPipe: a multidimensional spectral processing system based on UNIX pipes","volume":"6","author":"Delaglio","year":"1995","journal-title":"J.\u00a0Biomol. NMR"},{"key":"10.1016\/j.bbrc.2022.01.066_bib16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1006\/abio.2001.5047","article-title":"The ligand Affinity of proteins measured by isothermal denaturation kinetics","volume":"292","author":"Epps","year":"2001","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbrc.2022.01.066_bib17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ab.2004.04.031","article-title":"Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery","volume":"332","author":"Lo","year":"2004","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbrc.2022.01.066_bib18","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.jmb.2004.08.085","article-title":"Probing the high energy states in proteins by proteolysis","volume":"343","author":"Park","year":"2004","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.bbrc.2022.01.066_bib19","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.1021\/acs.biochem.7b00942","article-title":"Biological roles of protein kinetic stability","volume":"56","author":"Col\u00f3n","year":"2017","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2022.01.066_bib20","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3390\/hemato2040042","article-title":"Light chain stabilization: a therapeutic approach to Ameliorate al amyloidosis","volume":"2","author":"Morgan","year":"2021","journal-title":"Hemato"},{"key":"10.1016\/j.bbrc.2022.01.066_bib21","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.canlet.2018.10.016","article-title":"Gossypetin is a novel MKK3 and MKK6 inhibitor that suppresses esophageal cancer growth in\u00a0vitro and in\u00a0vivo","volume":"442","author":"Xie","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2022.01.066_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127203","article-title":"Non-\u2018classical\u2019 MEKs: a review of MEK3-7 inhibitors","volume":"30","author":"Kwong","year":"2020","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.bbrc.2022.01.066_bib23","doi-asserted-by":"crossref","DOI":"10.1186\/s12990-015-0011-8","article-title":"Small organic molecule disruptors of Cav3.2 - USP5 interactions reverse inflammatory and neuropathic pain","volume":"11","author":"Gadotti","year":"2015","journal-title":"Mol. Pain"},{"key":"10.1016\/j.bbrc.2022.01.066_bib24","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1021\/bi0600749","article-title":"Small molecule inhibitors of \u03b1-synuclein filament Assembly","volume":"45","author":"Masuda","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2022.01.066_bib25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.fct.2014.03.018","article-title":"Isoquercitrin: pharmacology, toxicology, and metabolism","volume":"68","author":"Valentov\u00e1","year":"2014","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bbrc.2022.01.066_bib26","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.3390\/molecules25102379","article-title":"Antiviral activities of quercetin and isoquercitrin against human herpesviruses","volume":"25","author":"Kim","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2022.01.066_bib27","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.3390\/nu12051353","article-title":"The protective effects of acer okamotoanum and isoquercitrin on obesity and amyloidosis in a mouse model","volume":"12","author":"Kim","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.bbrc.2022.01.066_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bpc.2010.02.004","article-title":"Protein kinetic stability","volume":"148","author":"Sanchez-Ruiz","year":"2010","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.bbrc.2022.01.066_bib29","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1126\/science.1079589","article-title":"Prevention of transthyretin amyloid disease by changing protein misfolding energetics","volume":"299","author":"Hammarstr\u00f6m","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2022.01.066_bib30","doi-asserted-by":"crossref","first-page":"14545","DOI":"10.1073\/pnas.0501609102","article-title":"Genistein, a natural product from soy, is a potent inhibitor of transthyretin amyloidosis","volume":"102","author":"Green","year":"2005","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X22000869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X22000869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:57:46Z","timestamp":1777377466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X22000869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":30,"alternative-id":["S0006291X22000869"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2022.01.066","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Compound screening identified gossypetin and isoquercitrin as novel inhibitors for amyloid fibril formations of V\u03bb6 proteins associated with AL amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2022.01.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}